Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation

NCT02067182 is registered in ClinicalTrials.gov with Georg Nickenig as lead sponsor.

NCT NCT02067182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02067182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
Lead sponsor
Georg Nickenig
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2015
Completion date
September 15, 2020
Enrollment
200 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardioembolic events, oral anticoagulation